• For Healthcare Professionals
  • Important Facts
SUNLENCA (lenacapavir) 463.5 mg/1.5 mL logo
  • About SUNLENCA
  • Dosing
  • Safety Information
  • Support

Site map

  • Home
  • About SUNLENCA®
  • Dosing
  • Support
  • Important Safety Information
  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Site Map

The information on this site is intended for audiences in the United States only. The content on this site may not apply to non-U.S. audiences as regulatory control, legal requirements, and/or medical practices may vary in other countries.

SUNLENCA, the SUNLENCA Logo, ADVANCING ACCESS, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc., or its related companies.

© 2023 Gilead Sciences, Inc. All rights reserved. US-LENC-0035 01/23

Gilead Logo

You are now leaving SUNLENCA.com
Would you like to continue?

Yes No